Introduction {#Sec1}
============

Obesity is associated with dysfunctions in central homeostatic regulation, which might also play a pivotal role in its pathogenesis^[@CR1],[@CR2]^. Energy homeostasis (i.e. the balance between food intake and energy expenditure) depends on signaling pathways in the hypothalamus, a small diencephalic brain region comprised of different sub-nuclei^[@CR3],[@CR4]^. Here, distinct subpopulations of neurons integrate circulating hormones that signal satiety (e.g. leptin, insulin) and hunger (e.g. ghrelin)^[@CR5]^.

Animal models support the hypothesis that a high-fat diet (HFD) triggers an inflammation-like response in the hypothalamus, which in turn impairs the sensing of anorexigenic signals, thereby contributing to continuous food intake and weight gain^[@CR6],[@CR7]^. For example, rodents fed a HFD showed increasing levels of proinflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF $\documentclass[12pt]{minimal}
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                \begin{document}$$\alpha $$\end{document}$) in the hypothalamus^[@CR8]^, even prior to substantial weight gain^[@CR9]^. This immunologic response was also accompanied by a rapid accumulation of microglia and recruitment of astrocytes^[@CR7],[@CR10]^. Additionally, hypothalamic neurons showed signs of toxic stress and underwent apoptosis after HFD^[@CR11]^. While some studies reported that this inflammation-like response declined after several days of overnutrition, suggesting a compensatory mechanism to prevent neurons from damage^[@CR12]^, others showed that gliosis and astrocytosis reoccurred after several weeks, pointing to prolonged changes in hypothalamic tissue and microstructural properties in obese animals^[@CR9]^.

Whether these neurobiological alterations shown in animal models of obesity also contribute to the pathophysiology of obesity in humans is however largely unknown. A post mortem analysis of obese and non-obese individuals reported that a higher BMI correlated with alterations in hypothalamic glia cells, which exhibited increased levels of dystrophy according to histological stainings^[@CR12]^. Studies using *in vivo* magnetic resonance imaging (MRI) linked volumetric changes in the hypothalamus to altered eating behavior within neurodegenerative and psychiatric disorders such as frontotemporal dementia or schizophrenia^[@CR13]--[@CR15]^. Two studies provided initial evidence for changes in hypothalamus T2-weighted MRI signals in relation to obesity: Thaler *et al*. showed increased signal ratio in a circular region-of-interest (ROI) in the left hypothalamus referenced to an amygdala-ROI in 12 obese compared to 11 non-obese participants^[@CR9]^. Another study including 67 participants reported higher T2-relaxation times in obesity within a ROI in the left mediobasal hypothalamus, and both studies proposed these measures as a marker of hypothalamic gliosis in diet-induced obesity^[@CR9],[@CR16]^. However, sample sizes were small and applying fixed ROIs could be misleading due to partial volume effects and the heterogenous appearance of the hypothalamus. In addition, the direction of effects was partly contradictory and a limited resolution and multiple sources of image artifacts limit interpretability^[@CR14],[@CR15],[@CR17]--[@CR19]^.

In sum, animal experiments and first, but not all, human studies support the hypothesis that central homeostatic changes reflected in compromised (micro)structure of the hypothalamus are present in obesity. However, methodology in the human studies remained unconvincing so far^[@CR18],[@CR20]--[@CR22]^. We therefore applied advanced voxel-wise MRI techniques^[@CR23],[@CR24]^ to determine whether larger hypothalamic volume and higher hypothalamic mean diffusivity (MD), derived by diffusion tensor imaging (DTI) and commonly interpreted as less intact cellular microstructure^[@CR25],[@CR26]^, are positively associated with obesity measured using BMI in a well-characterized large population-based sample. We also explored whether hypothalamic MD was linked to higher visceral adipose tissue volume (VAT), given the elevated inflammatory risk profile of this body fat depot^[@CR27]^. We additionally implemented a multi-atlas based label segmentation to validate our results in another independent sample.

Results {#Sec2}
=======

Hypothalamic volume {#Sec3}
-------------------

In a sample of 338 participants (48% females, aged 21--78 years, BMI range of 18--43 kg/m²), we delineated the left and right hypothalamus on T1-weighted anatomical MRI using a state-of-the-art semi-automated segmentation algorithm resulting in individual hypothalamic masks at the voxel-level (Fig. [1A](#Fig1){ref-type="fig"}, see Methods for details).Figure 1The hypothalamus on multimodal MRI. (**A**) The bilateral hypothalamus (right: red, left: orange) of a representative participant according to semi-automated segmentation on anatomical images. (**B**) Coregistration of the T1-weighted (T1w)-derived hypothalamus mask to the mean diffusivity (MD) image derived by diffusion-weighted imaging. Note the sparing of hypothalamus voxels which are affected by partial volume effects on the MD image (arrows). Images are shown in radiological convention.

On average, men showed 4.4% larger head-size adjusted whole hypothalamic volumes than women (*n*~1~ = 338; 48% females, aged 21--78 years, BMI range of 18--43 kg/m²; Fig. [2](#Fig2){ref-type="fig"}). The difference was statistically significant (standardized β = −0.18, p \< 0.001) according to a multiple regression model (adjusted R^2^ = 0.24, F~4,333~ = 26.9, p \< 0.001), controlled for potential effects of age (no significant contribution, p = 0.96), and rater (standardized β~0,1~ = −0.47, p \< 0.001, standardized β~0,2~ = −0.16, p = 0.001). Multi-collinearity of BMI and age was small (variance inflation factor \< 2). Adding BMI as additional predictor to the model did not improve the model fit (p = 0.59) indicating that BMI was not associated with hypothalamic volume.Figure 2Sex differences in hypothalamic volume. Analysis of hypothalamic volume reveals bigger values for male than for female participants (p \< 0.001).

When investigating the hemispheres separately, we observed higher volume for the left than for the right hypothalamus, an effect which was slightly less pronounced in women and independent of age and rater (linear mixed effect model, side: β = −40.9, p \< 0.001; sex: β = −26.5, p \< 0.001; side-by-sex interaction: β = 8.3, p = 0.048; rater: β~0,1~ = −52.4/β~0,2~ = −39.3, p \< 0.001; age: p = 0.78).

BMI and hypothalamic microstructure {#Sec4}
-----------------------------------

Next, we examined average MD within the individual's hypothalamus using DTI as a sensitive measure of microstructural properties^[@CR25],[@CR28]^. A carefully designed processing pipeline ensured that DTI-related distortions adjacent to the hypothalamus region did not bias hypothalamic MD estimates (Fig. [1B](#Fig1){ref-type="fig"}, see Methods for details).

According to linear regression, BMI significantly predicted hypothalamic MD (standardized β = 0.14, p = 0.008), showing that higher BMI was related to higher MD (Fig. [3A](#Fig3){ref-type="fig"}). The regression model (F~5,305~ = 19.95, p \< 0.001, adjusted R^2^ = 0.23) adjusted for potential effects of sex (standardized β = −0.39, p \< 0.001), age (standardized β = 0.38, p \< 0.001), and rater (n.s., p = 0.42). Men had larger MD than women and higher age was linked to higher MD. Adding BMI as predictor explained 1.5% more variance in hypothalamic MD than a model without BMI (F~1,300~ = 6.9, p = 0.008).Figure 3Obesity and hypothalamic microstructure. Higher body mass index (BMI) significantly predicts higher hypothalamic mean diffusivity (MD), commonly interpreted as less intact cellular microstructure, in a first (**A**, n~1~ = 311, comparison to age, sex-corrected model, F~1,306~ = 7.1, p = 0.008) and a second independent sample (**B**, n~2~ = 236, comparison to age, sex-corrected model, F~1,232~ = 4.2, p = 0.041). Line indicates regression fit with 95% confidence interval.

To rule out that higher BMI was related to a general increase of MD in subcortical gray matter (e.g. due to imaging artifacts), we tested whether BMI also predicted MD in the hippocampus. Here, we found no association of BMI and hippocampus MD (F-test comparing linear regression models with and without BMI, adjusted for age and sex, F = 0.13, p = 0.72, n = 291). When adding hippocampus MD as a confounder to the model of hypothalamic MD, the positive association of BMI and hypothalamic MD remained significant, even though attenuated (standardized β = 0.096, p = 0.05, n = 291). Additionally, to account for partial volume effects between hypothalamic and non-hypothalamic tissue, we included the volume of the 3rd ventricle and the hypothalamic volume as covariates into this model. This did not further attenuate the positive association of BMI and hypothalamic MD (standardized β = 0.09, p = 0.05, n = 291), indicating that the BMI-associated MD increase was not driven by a contamination of the MD signal due to cerebrospinal fluid.

Confirmatory analysis {#Sec5}
---------------------

To validate our findings in an independent sample, we developed a novel multi-label fusion atlas based on the initial segmentations that automatically generates individual hypothalamic segmentations (Fig. [4](#Fig4){ref-type="fig"}; see Methods for details). Using this atlas-approach in a second group of 236 participants confirmed a significant association between higher BMI and higher hypothalamus MD in similar magnitude (standardized β = 0.14, p = 0.04, Fig. [3B](#Fig3){ref-type="fig"}**;** regression model: F~3,232~ = 15.5, p \< 0.001, adjusted R^2^ = 0.16), adjusted for age (standardized β = 0.30, p \< 0.001) and sex (standardized β = −0.22, p = 0.07). Changes in F-values confirmed that adding BMI increased the explained variance of hypothalamic MD significantly by 1.2% (F~1,232~ = 4.2, p = 0.04). Similar to the initial sample, when adding hippocampal MD and ventricular volume to the model, BMI remained a significant predictor of hypothalamic MD. Furthermore, consideration of obesity-associated biomarkers (systolic blood pressure and HOMA-IR) as possible confounders did also not attenuate the positive association between BMI and hypothalamic MD. We report good to excellent reliability (ICC \> 0.87) between the semi-automated and the fully-automated segmentation procedures for hypothalamus MD.Figure 4Multi-atlas fusion segmentation for automated hypothalamus segmentation. (**A**) In the registration step both atlas and target images were non-linearly registered to a template image. In this common space another non-linear registration of atlas images to the target image was performed. (**B**) In the label propagation step all transformations were concatenated and the atlas hypothalami were brought into the native space of the target image (upper images show different label propagations for the same target subject, yellow: propagated label, red: manual label, orange: overlap). Fusion of the region of interest was performed using STEPS (lower image, yellow: fused label, red: manual label, orange: overlap see text for details).

Exploratory analysis of visceral fat {#Sec6}
------------------------------------

To explore whether visceral obesity explained more variance in hypothalamic MD than BMI, we compared two linear regression models, which included BMI (Model 1) and log-transformed height-corrected VAT (Model 2) along with age, sex and rater. VAT was estimated from T1-weighted abdominal MRI in a subset of the initial sample (n = 306, see Methods for details). We found that the association between VAT and hypothalamic MD (standardized β = 0.14, p = 0.029, adj. R^2^ = 0.232) was of similar magnitude than the link between BMI and hypothalamic MD (standardized β = 0.14, p = 0.007, adj. R^2^ = 0.238) when adjusting for age, sex and rater. We conclude that in this sample VAT had a similar sensitivity in predicting hypothalamic MD than BMI.

Discussion {#Sec7}
==========

Using multimodal neuroimaging in two large samples of healthy adults, we showed that higher BMI is associated with higher proton diffusivity in the hypothalamus, indicating hypothalamic microstructural alterations in obesity. In parallel, while men had higher hypothalamus volumes than women and the volume of the left hemispheric hypothalamus was larger than the right, BMI was not associated with hypothalamic volume.

BMI and hypothalamic microstructure {#Sec8}
-----------------------------------

Our findings provide evidence that higher BMI is associated with compromised microstructure in the hypothalamus. While the effect size is to be considered small, explaining 1.2--1.5% of the variance in hypothalamus MD, we confirmed our findings in another large independent sample. Our results are in line with and extend previous animal and human studies reporting obesity-related alterations in hypothalamic microstructure assessed with T2-weighted imaging, though previous human studies were based on limited sample sizes, suffered from two-dimensional assessments of the hypothalamus and have used less established markers of microstructure^[@CR9],[@CR20],[@CR22],[@CR29],[@CR30]^. In contrast, DTI-derived MD in grey matter regions, as used in the current study, reflects the amount, density or integrity of neuronal membranes, dendrites, axons, or glial compartments, that restrict water diffusion in the tissue in both animals and humans^[@CR25],[@CR26],[@CR29]^. Previous work showed that higher MD for example in the hippocampus correlated with poorer memory function^[@CR28]^. This might indicate that obesity-associated higher MD in the hypothalamus goes along with microstructural changes that could lead to dysfunctional outcomes. We also found higher values of hypothalamic MD in men than in women as well as an age-related increase in MD. The latter is supported by a broad range of studies that consistently found positive associations between diffusion metrics (such as MD and FA) and age in various GM structures, often in line with worse cognitive performance^[@CR31],[@CR32]^.

Yet, despite of being able to detect alterations on a cellular level, DTI metrics such as MD suffer from non-specificity and are confounded by tissue geometry. Accordingly, MD has been linked to various neurological disorders as well as to unspecific cerebral abnormalities such as edema, necrosis, demyelination or augmented cellularity^[@CR25]^. Therefore, various underlying mechanisms might explain the obesity-associated increases in hypothalamic MD in our study.

First, as discussed in the concept of hypothalamic inflammation, changes in MD might be attributed to a sustained gliosis as a consequence of diet-induced obesity. This is supported by findings in mice showing that microgliosis and astrocytosis returned permanently in mice fed a HFD, although temporarily subsiding^[@CR9]^. In addition, another study suggested microglial responses due to ongoing malnutrition in humans as they also detected signs of gliosis and microglial dystrophy in human hypothalamus assessed by post mortem stereology^[@CR12]^.

Second, hypothalamic inflammation in mice is also linked to a loss of hypothalamic neurons that underwent apoptosis as a consequence of the HFD^[@CR11]^. Therefore, the observed diffusion alteration might also be due to an enhanced amount of extracellular fluid that is accompanied by the neuronal loss or the neuroinflammation in general^[@CR33]^.

Another possible explanation for the increase in MD addresses vessel integrity, as it has been shown that HFD triggers hypothalamic angiopathy in mice with increased vessel density and length^[@CR34]^. Currently, new approaches are underway that aim to disentangle the changes in diffusion metrics driven by blood perfusion originating from the extracellular space^[@CR35]^.

Taken together, MD was positively associated with BMI in two large samples. While this suggests small, but reliable alterations in the hypothalamic microstructure in obese humans, the underlying histological mechanisms remain elusive. We encourage future studies to link our neuroimaging findings with advanced analysis at the cellular level (e.g. post-mortem stereology) to further explore the underlying mechanisms.

Hypothalamic volume {#Sec9}
-------------------

Our voxel-wise estimations of hypothalamic volume in a total of 338 participants, which is the largest sample of hypothalamic volumes obtained by semi-automated segmentation to date, adds to previous reports that whole hypothalamic volume assessed by MRI techniques is around 1 cm^3^ ^[@CR23]^. Reliability analysis revealed acceptable to excellent intra-rater and inter-rater reliabilities of hypothalamus volume and spatial overlap of resulting masks using this method. This highlights the sensitivity and specificity of our procedure and compares to previous high-quality segmentation protocols implemented in smaller sample sizes^[@CR13],[@CR19],[@CR36]^.

We also found that hypothalamic volumes were higher for males compared to females, irrespective of head size, age and BMI. This finding might be attributable to known sex differences in metabolic dysregulation^[@CR37]^ and the neuroendocrine regulation system^[@CR38]^. Furthermore, we found a significant left-right asymmetry in hypothalamic volume with higher volumes for the left than for the right hypothalamus, which is in line with a previous publication that described a trend in the same direction in a sample of 84 subjects^[@CR24]^. Along these lines, some hypothalamic functions have been described as lateralized to the left^[@CR39]^. Recent studies also suggest the hypothalamus to be involved in a lateralized brain circuit that mediates feeding behavior and homeostatic regulation^[@CR40]^. Future studies need to explore whether these processes might also contribute to volumetric asymmetry in hypothalamic volume.

We did not find a significant relationship between hypothalamic volume and BMI, controlling for the impact of age, sex and the different raters. Although a wide range of literature demonstrate that higher BMI is associated with lower GM volumes in various brain regions^[@CR41]^, evidence for significant changes in hypothalamic volumes associated with obesity is less observed^[@CR42],[@CR43]^. Nevertheless, BMI has been shown to be related to functional alterations in several brain circuits that involve the hypothalamus^[@CR44]^. Interestingly, while age-related atrophy in various subcortical structures is commonly observed^[@CR45]^, age was not related to hypothalamic volume in the present cohort.

Limitations and strengths {#Sec10}
-------------------------

Some limitations need to be taken into consideration. As our dataset is cross-sectional, we cannot infer causality. Altered hypothalamic microstructure might be attributable to both, prerequisite or consequence, of obesity. Furthermore, even if referring to established concepts such as hypothalamic inflammation, knowledge about the temporal dynamics of this inflammatory process is scarce or inconsistent^[@CR12]^. Also, hypothalamus physiological function is not restricted to energy metabolism and homeostasis, and we were not able to dissect the hypothalamus in its sub-nuclei. Thus, we cannot rule out whether the arcuate nucleus, although relatively large, and/or other hypothalamus subnuclei, serving as main hubs in the control of fluid balance, circadian rhythms or thermoregulation^[@CR46]^, contributed to the average hypothalamic MD signal. In addition, the usage of BMI to characterize obesity might be too simplistic^[@CR27]^. However, our results incorporating MRI-based measures of VAT, indicative of visceral obesity, indicate that VAT did not explain more variance in hypothalamic microstructure than BMI. Arguments for the robustness and specificity of our findings stem from covariate adjustments for age, sex and other potential confounders. Particularly, considering hippocampal MD, HOMA-IR and systolic blood pressure in our statistical analysis did not attenuate the association between obesity and hypothalamic MD in our validation sample. This indicates that the observed association was primarily due to neither global effects nor obesity-associated conditions such as insulin resistance. Reliability analyses indicated good to excellent fits between the MD-methods used in the two samples. Further strengths of our study include the large, well-characterized population-based sample size, a thorough methodological design combining a semi-automated segmentation algorithm with sensitive DTI metrics, along with confirmation analysis in an independent sample.

Conclusion {#Sec11}
==========

Using a novel multimodal MRI approach in two large samples of healthy adults of the general population, we were able to demonstrate that a higher BMI specifically relates to higher MD in the hypothalamus, independent from confounders such as age, sex and obesity-associated co-morbidities. This finding thus points to persisting microstructural alterations in a key regulatory area of energy homeostasis occurring with excessive weight. The underlying mechanisms might include inflammatory activity, neuronal degeneration or angiopathy in the hypothalamus due to obesity-related overnutrition and metabolic alterations. Future studies need to test the functional relevance of these microstructural changes, and if interventions aiming to reduce obesity can effectively reverse the observed changes in hypothalamic MD.

Material and Methods {#Sec12}
====================

Participants {#Sec13}
------------

Participants were recruited randomly as part of the MRI-subsample within the "Health Study for the Leipzig Research Centre for Civilization Diseases" (LIFE-Adult) study^[@CR47]^. The study was approved by the Ethics Committee of the University of Leipzig and all participants gave informed written consent. All methods were performed in accordance with the ethical guidelines of the World Medical Association (Declaration of Helsinki). In total, 2637 adults received brain MRI. We selected participants without history of stroke, cancer, epilepsy, multiple sclerosis and Parkinson's disease, neuroradiological findings of brain pathology or intake of centrally active medication (n = 2095, for a flowchart, see Fig. [5](#Fig5){ref-type="fig"}). Further, only a well-characterized subgroup with abdominal MRI to assess visceral adipose tissue (VAT) was considered (n = 993). Out of these, two raters segmented 166 and 152 participants, respectively. For test-retest and interrater-reliability both raters additionally segmented 20 participants twice. In total, bilateral hypothalami were segmented in n = 338 participants (*n*~1~, for demographic characteristics, see Table [1](#Tab1){ref-type="table"}). Twenty-seven participants had to be removed from diffusion-weighted image analysis due to incomplete or deficient imaging data. For confirmatory analyses, we additionally examined another n = 236 of the pool of participants with additional abdominal MRI using multi-atlas fusion segmentation (*n*~2~, see Fig. [5](#Fig5){ref-type="fig"} and below for details).Figure 5Flowchart of the study illustrating the exclusion criteria, the subsample sizes and the different approaches of data analysis.Table 1Demographic characteristics of the semi-manual segmentation sample n~1~, separated by sex.FemaleMalen162176Age (years)54.36 ± 11.48 (23--77)55.64 ± 13.12 (21--78)BMI (kg/m^2^)25.67 ± 4.13 (17.68--38.10)27.08 ± 3.60 (19.28--43.09)VAT^a^ (cm^3^)1600.04 ± 933.75 (232.76--4677.73)3037.96 ± 1442.72 (379.28--7584.29)Data is given as mean ± standard deviation (SD) and range (minimum -- maximum).^a^n = 331 due to missing values of VAT.BMI: body mass index, VAT: visceral adipose tissue.

Anthropometry {#Sec14}
-------------

Body weight was measured with a scale with a precision of 0.01 kg and body height was assessed using the means of a stadiometer to the nearest 0.1 cm. BMI was calculated as body weight \[kg\] divided by squared body height \[m\].

Obesity-related biomarkers {#Sec15}
--------------------------

We collected additional obesity-related biomarkers in a subset of participants. Laboratory indicators of glucose metabolism (glucose and insulin) were obtained after overnight fasting according to standard procedures^[@CR47]^ and used to calculate insulin resistance with the homeostatic model assessment (HOMA-IR)^[@CR48]^. Blood pressure was measured with an automatic oscillometric blood pressure monitor (OMRON 705IT, OMRON Medizintechnik Handelsgesellschaft mbH).

Magnetic resonance imaging {#Sec16}
--------------------------

Magnetic resonance imaging (MRI) was performed on a 3 T Magnetom Verio scanner (Siemens, Erlangen, Germany, equipped with a 32-channel head array coil and syngo MR B17 software).

Abdominal MRI acquisition and preprocessing {#Sec17}
-------------------------------------------

MRI of the abdomen was performed using an axial T1-weighted fast spin-echo technique with the following parameters: repetition time, 520 ms; echo time, 18 ms; 5-mm gap between slicefield of view, 500 mm 375 mm; final voxel size 1.6 × 1.6 × 5.0 mm^3^. Beginning 10 cm below the umbilicus, 5 slices were recorded from feet-to-head direction with 5 cm table shift after each acquisition and finishing in the liver region^[@CR47]^. Using a semi-automated segmentation algorithm implemented in ImageJ (<https://imagej.nih.gov/ij/download/>), visceral adipose tissue (VAT) was obtained from 20 slices centered around the participant's umbilicus^[@CR49]^. For subsequent analysis, the VAT volume was log-transformed and normalized by height.

Head MRI acquisition and preprocessing {#Sec18}
--------------------------------------

Anatomical MRI was acquired using a T1-weighted Magnetization prepared rapid gradient echo (MPRAGE) pulse sequence with the following parameters: inversion time, 900 ms; repetition time, 2.3 ms; echo time, 2.98 ms; flip angle, 98; image matrix, 256 176 240; voxel size, 1 × 1 × 1 mm^3^.

Preprocessing of the anatomical T1-weighted data included skullstripping and realignment to anterior and posterior commissure using in-house software Lipsia (<https://www.cbs.mpg.de/institute/software/lipsia/download>). Then, tissue segmentation was performed with the default settings using SPM12's New Segment based on Matlab version 2017b.

For DTI metrics, Diffusion weighted imaging (DWI) was acquired with a twice-refocused echo planar imaging sequence (EPI) with the following parameters: repetition time, 13800 ms; echo time, 100 ms;; image matrix 128 × 128; 72 slices; voxel size 1.7 × 1.7 × 1.7 mm^3^; 60 directions with b-value 1000 s/mm^2^, and 7 volumes with b-value 0 s/mm^2^.

Preprocessing included denoising (MRtrix v3.0) of the raw data removal of gibbs‐ringing artifact from all b0 images using the local subvoxel-shift method and outlier replacement using the eddy tool in FSL 5.0.10^[@CR50]--[@CR53]^. Subsequently, data was corrected for head motion and linearly coregistered to the T1 image with Lipsia tools. Finally, we applied tensor model fitting and generated mean diffusivity (MD) and fractional anisotropy (FA) images.

Semi-automated segmentation of the hypothalamus {#Sec19}
-----------------------------------------------

Based on previously established protocols for 3 T MRI data^[@CR24]^, we performed semi-automated segmentation of the hypothalamus in MeVisLab 4.1. Briefly, a preoptic, an intermediate-superior and --inferior as well as a posterior region of interest (ROI) was manually pre-defined by two raters using the following landmarks: anterior commissure, columna fornicis, interventricular foramen, mamillary bodies, zona incerta and hypothalamic sulcus^[@CR24]^. Due to some false-positive segmentation results of intraventricular voxels with the original approach, we adapted the medial landmarks according to Mai, Majtanik & Paxinos^[@CR54]^. Next, grey matter tissue probability masks were overlaid on each ROI and predefined grey matter thresholds were used to define hypothalamus area. Then all slices were combined to generate a three-dimensional volume of the hypothalamus (Fig. [2A](#Fig2){ref-type="fig"}). Subsequently, each rater checked the results carefully in a triplanar view with regard to plausibility and coherence to the predefined anatomical edges.

To perform intra- and interrater reliability analysis, we selected 20 additional participants that were segmented twice by both raters. We ensured that reliability subjects were comparable to the whole segmentation sample with respect to age, sex and BMI. According to Shrout & Fleiss^[@CR55]^, intraclass correlation coefficients (ICC) were calculated using model 1,1 and 3,1. We considered an ICC ≥ 0.9 excellent, 0.9 \> ICC ≥ 0.8 good and 0.8 \> ICC ≥ 0.7 acceptable^[@CR56]^. Additionally, percentage of relative overlap between the two raters was assessed using Dice similarity coefficient (DSC)^[@CR57]^. An overlap of 70, 80 or 90% (DSC = 0.7, 0.8, 0.9) was regarded acceptable, good and excellent, respectively. All ICC and DSC values showed acceptable to excellent agreements (Supplementary Tab. 1).

The segmentation procedure was conducted separately for left and right hypothalamus and took between 30 and 45 minutes per brain. Hypothalamic volumes were assessed by extracting the number of voxels for each side. Whole hypothalamic volume was calculated by summing up volumes of left and right hypothalamus. As subcortical volumes are trivially linked to total intracranial volume, hypothalamic volume was adjusted using the following formula^[@CR58]^:$$\documentclass[12pt]{minimal}
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For the statistical analysis, we considered rater as a variable with three levels: rater 1, rater 2 and "rater1/2". For these 20 reliability subjects, we used the average of the two measurements by the two raters.

Extraction of the hypothalamus mean diffusivity {#Sec20}
-----------------------------------------------

Derived by DTI, we used MD as a sensitive measure of microstructural properties^[@CR25],[@CR28]^. Briefly, MD reflects the overall amount of diffusion in a certain voxel, and we averaged this measure in the hypothalamic ROI. A carefully designed processing pipeline ensured that DTI-related distortions adjacent to the hypothalamus region did not bias hypothalamic MD estimates (Fig. [2B](#Fig2){ref-type="fig"}). FA images of all subjects with hypothalamic volumetry were coregistered to the respective anatomical images with FSL's FLIRT using 6 degrees of freedom. Then, the registration matrix was used to coregister the MD images to the anatomical space. 24 participants did not receive diffusion weighted imaging or had incomplete data. Furthermore, coregistration failed in 3 subjects, resulting in 311 participants eligible for MD analysis in sample *n*~1~.

Due to its small size, minor shifts or artifacts within the overlay of hypothalamus and the MD mask might be detrimental for analysis, especially for hypothalamic and non-hypothalamic voxels adjacent to the third ventricle (Fig. [2B](#Fig2){ref-type="fig"}). In order to avoid that intraventricular voxels were regarded as hypothalamic tissue, further processing was required to distinguish these voxels from those in hypothalamic tissue with regard to MD. Consequently, we derived the average MD in the third ventricle based on the automatic segmentation in FreeSurfer version 5.3.0. Expecting that grey matter (hypothalamus) MD is smaller than MD in cerebrospinal fluid (third ventricle)^[@CR59]^, average MD of the whole third ventricle was chosen as a threshold for the hypothalamic MD. Specifically, the MD value of each putative hypothalamic voxel was compared to the average MD of the whole third ventricle. Unless MD of each voxel was higher than the average MD of the third ventricle, this voxel was considered hypothalamic. Results were manually crosschecked. Finally, average MD of all voxels that were likely to be hypothalamic tissue was extracted.

Statistical analysis of hypothalamic volume and diffusivity {#Sec21}
-----------------------------------------------------------

R version 3.2.3 was used to perform statistical analysis.

BMI-related differences in whole hypothalamic volume and MD were assessed by two groups of regression models. For both hypothalamic volume and MD, we compared the null model (including age, sex and rater as predictors) against a regression model including BMI as an additional predictor. The difference between the model was assessed using a likelihood ratio test and a p-value \< 0.05 was regarded as statistically significant. To test the specificity of the finding and exclude confounding of ventricular volume, we additionally tested a model including the MD of the hippocampus and the ventricular volume as predictors^[@CR28]^.

Hemispheric and sex differences of hypothalamic volume were evaluated in a linear mixed model using the function lmer from the R-package lme4. This model included a side-by-sex interaction, rater and age as predictors and subject as a random factor. We report β estimates and p-values based on likelihood ratio tests-based for the fixed main and interaction effects.

Confirmatory analyses {#Sec22}
---------------------

### Multi-atlas fusion segmentation {#Sec23}

We aimed to confirm the above described MD-analyses in another independent sample. Therefore, we implemented a fully automated multi-label fusion hypothalamus segmentation procedure (Fig. [3](#Fig3){ref-type="fig"}). First, we created a study-specific template using n = 150 randomly selected participants with manual segmentations of the hypothalamus out of sample *n*~1~. This sub-sample did not differ from the final sample (*n*~1~ = 338) in age, sex, BMI or rater distribution (all p \> 0.05) (Supplementary Table [4](#MOESM1){ref-type="media"}).

To create the template, we applied the function buildtemplateparallel.sh implemented in ANTS version 2.2.0^[@CR60]^. For more details on the code see publicly available scripts (https://dx.doi.org/10.17617/3.2e). We then implemented a multi-atlas label fusion based on an intermediate template in nipype (for details, see Supplementary information)^[@CR61]--[@CR63]^.

Finally, we extracted the volume of the resulting hypothalamus segmentation and the ventricle-thresholded average MD values. We validated this approach in two samples.

First, we performed the multi-label fusion segmentation for each of the 44 participants from the template sample. We compared estimated hypothalamic volumes and MD with the values derived from the manual segmentation using ICC (model 3,1) and DSC. In this sample, three participants could not be included for the analysis of MD due to deficient DTI preprocessing.

In the second validation, we aimed to test whether the automated segmentation would perform equally well in participants who were not included into the template. Therefore, we randomly selected 24 participants with manual segmentations who were not part of the n = 150 template sample. The 44 participants from the first sample were used as atlas inputs, and we again calculated DSC and ICC to compare the manual and automated segmentation approaches.

After validation, we moved on to perform automated multi-atlas based segmentation of the hypothalamus in another sample of participants from our cohort with complete information on primary covariates, laboratory parameters, diffusion-weighted MRI etc. (*n*~2~ = 236, see Fig. [1](#Fig1){ref-type="fig"}). Again, the 44 participants were used as atlas inputs.

We extracted mean MD from the automatically segmented hypothalami and repeated the multiple regression analysis with age, sex and BMI as predictors. Likewise, we considered hippocampal MD and third ventricular volume as possible confounders. Additionally, since this sample had complete measures of blood pressure, glucose and insulin, we included log-transformed HOMA-IR and systolic blood pressure into the regression model.

### Validation of the multi-atlas fusion segmentation {#Sec24}

For both the template and the validation sample, we received low to acceptable ICCs (model 3,1) for the volumetric agreement between automatically segmented and manually segmented hypothalamus (Supplementary Table [2](#MOESM1){ref-type="media"}). Therefore, we abstained from using volumetric values from this fully automated segmentation in further analyses. Similar to the inter-rater comparison, the DSC between the automatically and manually segmented hypothalami were good with average values across participants of \>0.8 (Supplementary Table [2](#MOESM1){ref-type="media"}).

Regarding the MD, we observed good to excellent ICC between the values based on automatically segmented and manually segmented hypothalamic (Supplementary Table [3](#MOESM1){ref-type="media"}). In the validation sample 2 the ICC dropped slightly in the left compared to the right hemisphere but remained in the good range (ICC = 0.87).
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